30390.0000 325.00 (1.08%)
NSE May 13, 2025 15:31 PM
Volume: 6,003
 

30390.00
1.08%
Rudra Shares and Stock Brokers Ltd
Generic pharmaceuticals business has been trending well for Abbott Labs for some time now. It has a broad line of branded generic pharmaceuticals manufactured worldwide, and marketed and sold outside the U.S. The major products sold through this segment include Creon, Brufen, Biaxin, Influvac and Duphaston, among others. Looking forward, company expects double-digit...
Abbott India Ltd.'s price crossed above 30Day SMA today
More from Abbott India Ltd.
Recommended